尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Mulligan Richard, 董事. Director active across 3 companies, notably BIOGEN INC.. Aggregated, 8 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €547k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 16 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Richard Mulligan is a Board Member at Biogen Inc. and Bausch Health Companies Inc. He is involved in overseeing the operations of these companies and strategic decision-making. With experience in the biopharmaceutical sector, he contributes to the strategic direction of Biogen and Bausch Health, which focus on health innovation.